Investing Ideas
/
U.K. Pharmaceuticals & Biotech Spotless Management

U.K. Pharmaceuticals & Biotech Spotless Management

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.

1 companies

AstraZeneca

Market Cap: UK£211.4b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

AZN

UK£136.32

3.2%

25.4%